Literature DB >> 8462328

Natural history and epidemiology of malignant mesothelioma.

K H Antman1.   

Abstract

Asbestos exposure constitutes the primary cause of pleural and peritoneal mesothelioma in humans. Risk relates to the duration and intensity of exposure. Thus, those exposed at younger ages are at higher lifetime risk. Families of asbestos workers exposed to asbestos on hair and clothing as well as to asbestos items brought home from the workplace are also at risk, as are employees working in the same vicinity as asbestos workers. The public health significance of exposure from asbestos in public and private buildings remains controversial. Malignant mesothelioma is difficult to diagnose and carries a poor prognosis. Chemotherapy with single or multiple agents has thus far been disappointing, but doxorubicin and cisplatin or mitomycin and cisplatin are probably most active with response rates in measurable disease of 25%. Palliative radiotherapy is also problematic since differences between tumor cytotoxicity and pulmonary tolerance are small and radiation pneumonitis may significantly impair quality of life.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8462328     DOI: 10.1378/chest.103.4_supplement.373s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  23 in total

1.  Current issues in malignant pleural mesothelioma evaluation and management.

Authors:  Jing Ai; James P Stevenson
Journal:  Oncologist       Date:  2014-07-24

Review 2.  Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies.

Authors:  Andrew R Haas; Daniel H Sterman
Journal:  Clin Chest Med       Date:  2013-01-17       Impact factor: 2.878

3.  Subcutaneous metastasis of peritoneal mesothelioma diagnosed by fine-needle aspiration.

Authors:  Lina Pappa; Melpomeni Machera; Eleni Tsanou; Constantina Damala; Dimitrios Peschos; Maria Bafa; Vassiliki Malamou-Mitsi
Journal:  Pathol Oncol Res       Date:  2006-12-25       Impact factor: 3.201

Review 4.  Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment.

Authors:  Sandip Basu; Babak Saboury; Drew A Torigian; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

Review 5.  Late cutaneous metastases to the face from malignant pleural mesothelioma: a case report and review of the literature.

Authors:  Alaaeldeen M Elbahaie; Dia E Kamel; Julia Lawrence; Neville G Davidson
Journal:  World J Surg Oncol       Date:  2009-11-09       Impact factor: 2.754

6.  Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810).

Authors:  Sujith R Kalmadi; Cathryn Rankin; Michael J Kraut; Andrew D Jacobs; Daniel P Petrylak; David J Adelstein; Mary Louise Keohan; Robert N Taub; Ernest C Borden
Journal:  Lung Cancer       Date:  2007-11-19       Impact factor: 5.705

Review 7.  [Medical insurance aspects of peritoneal tumors with particular attention to peritoneal mesotheliomas].

Authors:  Volker Neumann; Stefan Löseke; Andrea Tannapfel
Journal:  Med Klin (Munich)       Date:  2009-10-25

8.  Factors influencing long-term survival in mesothelioma patients--results of the German mesothelioma register.

Authors:  V Neumann; A Rütten; M Scharmach; K-M Müller; M Fischer
Journal:  Int Arch Occup Environ Health       Date:  2004-02-27       Impact factor: 3.015

9.  Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses.

Authors:  Prasad S Adusumilli; Brendon M Stiles; Mei-Ki Chan; Michael Mullerad; David P Eisenberg; Leah Ben-Porat; Rumana Huq; Valerie W Rusch; Yuman Fong
Journal:  J Gene Med       Date:  2006-05       Impact factor: 4.565

10.  Mesothelioma in an HIV/AIDS patient without history of asbestos exposure: possible role for immunosuppression in mesothelioma: a case report.

Authors:  Cleve Orian James; Ashanti W Woods; Payam Arya; Khadega Ahmed Abuelgasim; Lekidelu Taddesse Heath; Amy Sitapati
Journal:  Cases J       Date:  2009-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.